224 related articles for article (PubMed ID: 22798683)
1. Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells.
Bak SP; Barnkob MS; Bai A; Higham EM; Wittrup KD; Chen J
J Immunol; 2012 Aug; 189(4):1708-16. PubMed ID: 22798683
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model.
Higham EM; Shen CH; Wittrup KD; Chen J
J Immunol; 2010 Jun; 184(11):5954-8. PubMed ID: 20427765
[TBL] [Abstract][Full Text] [Related]
3. Trogocytosis of CD80 and CD86 by induced regulatory T cells.
Gu P; Gao JF; D'Souza CA; Kowalczyk A; Chou KY; Zhang L
Cell Mol Immunol; 2012 Mar; 9(2):136-46. PubMed ID: 22307040
[TBL] [Abstract][Full Text] [Related]
4. A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
Oba T; Hoki T; Yamauchi T; Keler T; Marsh HC; Cao X; Ito F
J Immunol; 2020 Oct; 205(7):1867-1877. PubMed ID: 32848036
[TBL] [Abstract][Full Text] [Related]
5. T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity.
Lee SE; Shin AR; Sohn HJ; Cho HI; Kim TG
Cancer Res Treat; 2020 Jul; 52(3):747-763. PubMed ID: 32065848
[TBL] [Abstract][Full Text] [Related]
6. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420
[TBL] [Abstract][Full Text] [Related]
7. Regulating the expression of CD80/CD86 on dendritic cells to induce immune tolerance after xeno-islet transplantation.
Ke N; Su A; Huang W; Szatmary P; Zhang Z
Immunobiology; 2016 Jul; 221(7):803-12. PubMed ID: 26879762
[TBL] [Abstract][Full Text] [Related]
8. Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction.
Kim YJ; Park SJ; Broxmeyer HE
J Immunol; 2011 Sep; 187(5):2291-301. PubMed ID: 21795591
[TBL] [Abstract][Full Text] [Related]
9. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
[TBL] [Abstract][Full Text] [Related]
10. Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation.
Perez N; Karumuthil-Melethil S; Li R; Prabhakar BS; Holterman MJ; Vasu C
J Immunol; 2008 May; 180(10):6566-76. PubMed ID: 18453575
[TBL] [Abstract][Full Text] [Related]
11. Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting.
Keller AM; Xiao Y; Peperzak V; Naik SH; Borst J
Blood; 2009 May; 113(21):5167-75. PubMed ID: 19279334
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.
Kurtz J; Raval F; Vallot C; Der J; Sykes M
Blood; 2009 Apr; 113(15):3475-84. PubMed ID: 19179471
[TBL] [Abstract][Full Text] [Related]
13. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
[TBL] [Abstract][Full Text] [Related]
14. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
15. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
[TBL] [Abstract][Full Text] [Related]
16. Ligation of CD80 is critical for high-level CD25 expression on CD8+ T lymphocytes.
Pejawar-Gaddy S; Alexander-Miller MA
J Immunol; 2006 Oct; 177(7):4495-502. PubMed ID: 16982886
[TBL] [Abstract][Full Text] [Related]
17. Development of a potent melanoma vaccine capable of stimulating CD8(+) T-cells independently of dendritic cells in a mouse model.
Powell KL; Stephens AS; Ralph SJ
Cancer Immunol Immunother; 2015 Jul; 64(7):861-72. PubMed ID: 25893808
[TBL] [Abstract][Full Text] [Related]
18. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells.
Dilioglou S; Cruse JM; Lewis RE
Exp Mol Pathol; 2003 Aug; 75(1):18-33. PubMed ID: 12834622
[TBL] [Abstract][Full Text] [Related]
19. CD86 has sustained costimulatory effects on CD8 T cells.
Thomas IJ; Petrich de Marquesini LG; Ravanan R; Smith RM; Guerder S; Flavell RA; Wraith DC; Wen L; Wong FS
J Immunol; 2007 Nov; 179(9):5936-46. PubMed ID: 17947667
[TBL] [Abstract][Full Text] [Related]
20. Regulation of self-tolerance by CD80/CD86 interactions.
Lu P; Wang YL; Linsley PS
Curr Opin Immunol; 1997 Dec; 9(6):858-62. PubMed ID: 9492990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]